Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

NCT06643221 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Hematopoetic Stem Cell Transplantation
Donor Lymphocyte Infusion
CAR T-Cell Therapy
Lymphoma
Cell Therapy

Interventions

BEHAVIORAL: Exercise
DRUG: Isoproterenol
DRUG: Placebo
DRUG: Bisoprolol Fumarate Tablet 10 mg
DRUG: Nadolol (1 x 80 mg) Tablets (Invamed, Inc)
DRUG: Carvedilol 50 mg
DRUG: Roflumilast 500 Mcg Oral Tablet

Sponsor

University of Arizona

Collaborators

[object Object]